Skip to main content
Erschienen in: Rheumatology International 12/2012

01.12.2012 | Original Article

25-Hydroxyvitamin D levels and juvenile idiopathic arthritis: Is there an association with disease activity?

verfasst von: Christina F. Pelajo, Jorge M. Lopez-Benitez, David M. Kent, Lori Lyn Price, Laurie C. Miller, Bess Dawson-Hughes

Erschienen in: Rheumatology International | Ausgabe 12/2012

Einloggen, um Zugang zu erhalten

Abstract

The aims of this study were to examine the association between serum levels of 25-hydroxyvitamin D [25(OH)D] and disease activity in juvenile idiopathic arthritis (JIA), to determine the prevalence of vitamin D (VD) deficiency [25(OH)D ≤19 ng/ml] and insufficiency [25(OH)D 20–29 ng/ml], and to determine factors associated with lower serum levels of 25(OH)D in this population. In this cross-sectional study, disease activity was measured using JADAS-27, as well as its individual components (physician global assessment of disease activity, parent global assessment of child’s well-being, count of joints with active disease, and erythrocyte sedimentation rate). Linear regression models were developed to analyze the association between serum 25(OH)D levels and JADAS-27 and to determine variables associated with serum 25(OH)D levels. A total of 154 patients (61% girls, 88% whites) were included. Mean age was 10.6. VD deficiency was detected in 13% and insufficiency in 42%. In univariate and multivariate analyses, 25(OH)D levels were not associated with JADAS-27, neither with its individual components. However, in a subset analysis including all new-onset JIA patients (n = 27), there was a nonsignificant negative correlation between serum 25(OH)D levels and JADAS-27 (r = −0.29, P = 0.14). In the univariate and multivariate analyses, age, ethnicity, BMI, and season were significantly associated with serum 25(OH)D levels, but not total VD intake. More than 1/2 of JIA patients had serum 25(OH)D levels below 29 ng/ml; however, there was no association between serum 25(OH)D levels and disease activity. Future larger, long-term studies with new-onset JIA patients are needed to further explore the association between serum 25(OH)D levels and disease activity.
Literatur
3.
Zurück zum Zitat Chen S, Sims GP, Chen XX, Gu YY, Lipsky PE (2007) Modulatory effects of 1, 25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol 179(3):1634–1647. doi:179/3/1634 PubMed Chen S, Sims GP, Chen XX, Gu YY, Lipsky PE (2007) Modulatory effects of 1, 25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol 179(3):1634–1647. doi:179/​3/​1634 PubMed
4.
Zurück zum Zitat Jirapongsananuruk O, Melamed I, Leung DY (2000) Additive immunosuppressive effects of 1, 25-dihydroxyvitamin D3 and corticosteroids on TH1, but not TH2, responses. J Allergy Clin Immunol 106(5):981–985. doi:10.1067/mai.2000.110101 PubMedCrossRef Jirapongsananuruk O, Melamed I, Leung DY (2000) Additive immunosuppressive effects of 1, 25-dihydroxyvitamin D3 and corticosteroids on TH1, but not TH2, responses. J Allergy Clin Immunol 106(5):981–985. doi:10.​1067/​mai.​2000.​110101 PubMedCrossRef
5.
Zurück zum Zitat Lemire J (2000) 1, 25-Dihydroxyvitamin D3—a hormone with immunomodulatory properties. Z Rheumatol 59(Suppl 1):24–27PubMedCrossRef Lemire J (2000) 1, 25-Dihydroxyvitamin D3—a hormone with immunomodulatory properties. Z Rheumatol 59(Suppl 1):24–27PubMedCrossRef
6.
Zurück zum Zitat Lemire JM, Archer DC, Beck L, Spiegelberg HL (1995) Immunosuppressive actions of 1, 25-dihydroxyvitamin D3: preferential inhibition of Th1 functions. J Nutr 125(6 Suppl):1704S–1708SPubMed Lemire JM, Archer DC, Beck L, Spiegelberg HL (1995) Immunosuppressive actions of 1, 25-dihydroxyvitamin D3: preferential inhibition of Th1 functions. J Nutr 125(6 Suppl):1704S–1708SPubMed
8.
Zurück zum Zitat van Halteren AG, Tysma OM, van Etten E, Mathieu C, Roep BO (2004) 1 alpha, 25-dihydroxyvitamin D3 or analogue treated dendritic cells modulate human autoreactive T cells via the selective induction of apoptosis. J Autoimmun 23(3):233–239. doi:10.1016/j.jaut.2004.06.004 PubMedCrossRef van Halteren AG, Tysma OM, van Etten E, Mathieu C, Roep BO (2004) 1 alpha, 25-dihydroxyvitamin D3 or analogue treated dendritic cells modulate human autoreactive T cells via the selective induction of apoptosis. J Autoimmun 23(3):233–239. doi:10.​1016/​j.​jaut.​2004.​06.​004 PubMedCrossRef
12.
13.
Zurück zum Zitat Muller K, Kriegbaum NJ, Baslund B, Sorensen OH, Thymann M, Bentzen K (1995) Vitamin D3 metabolism in patients with rheumatic diseases: low serum levels of 25-hydroxyvitamin D3 in patients with systemic lupus erythematosus. Clin Rheumatol 14(4):397–400PubMedCrossRef Muller K, Kriegbaum NJ, Baslund B, Sorensen OH, Thymann M, Bentzen K (1995) Vitamin D3 metabolism in patients with rheumatic diseases: low serum levels of 25-hydroxyvitamin D3 in patients with systemic lupus erythematosus. Clin Rheumatol 14(4):397–400PubMedCrossRef
14.
Zurück zum Zitat Ruiz-Irastorza G, Egurbide MV, Olivares N, Martinez-Berriotxoa A, Aguirre C (2008) Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences. Rheumatology (Oxford) 47(6):920–923. doi:10.1093/rheumatology/ken121 CrossRef Ruiz-Irastorza G, Egurbide MV, Olivares N, Martinez-Berriotxoa A, Aguirre C (2008) Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences. Rheumatology (Oxford) 47(6):920–923. doi:10.​1093/​rheumatology/​ken121 CrossRef
16.
17.
Zurück zum Zitat Becker A, Fischer R, Schneider M (2001) Bone density and 25-OH vitamin D serum level in patients with systemic lupus erythematosus. Z Rheumatol 60(5):352–358PubMedCrossRef Becker A, Fischer R, Schneider M (2001) Bone density and 25-OH vitamin D serum level in patients with systemic lupus erythematosus. Z Rheumatol 60(5):352–358PubMedCrossRef
19.
Zurück zum Zitat Merlino LA, Curtis J, Mikuls TR, Cerhan JR, Criswell LA, Saag KG (2004) Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women’s Health Study. Arthritis Rheum 50(1):72–77. doi:10.1002/art.11434 PubMedCrossRef Merlino LA, Curtis J, Mikuls TR, Cerhan JR, Criswell LA, Saag KG (2004) Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women’s Health Study. Arthritis Rheum 50(1):72–77. doi:10.​1002/​art.​11434 PubMedCrossRef
20.
21.
Zurück zum Zitat Patel S, Farragher T, Berry J, Bunn D, Silman A, Symmons D (2007) Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis. Arthritis Rheum 56(7):2143–2149. doi:10.1002/art.22722 PubMedCrossRef Patel S, Farragher T, Berry J, Bunn D, Silman A, Symmons D (2007) Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis. Arthritis Rheum 56(7):2143–2149. doi:10.​1002/​art.​22722 PubMedCrossRef
22.
Zurück zum Zitat Cutolo M, Otsa K, Laas K, Yprus M, Lehtme R, Secchi ME, Sulli A, Paolino S, Seriolo B (2006) Circannual vitamin d serum levels and disease activity in rheumatoid arthritis: Northern versus Southern Europe. Clin Exp Rheumatol 24(6):702–704. doi:1964 PubMed Cutolo M, Otsa K, Laas K, Yprus M, Lehtme R, Secchi ME, Sulli A, Paolino S, Seriolo B (2006) Circannual vitamin d serum levels and disease activity in rheumatoid arthritis: Northern versus Southern Europe. Clin Exp Rheumatol 24(6):702–704. doi:1964 PubMed
23.
Zurück zum Zitat Oelzner P, Muller A, Deschner F, Huller M, Abendroth K, Hein G, Stein G (1998) Relationship between disease activity and serum levels of vitamin D metabolites and PTH in rheumatoid arthritis. Calcif Tissue Int 62(3):193–198PubMedCrossRef Oelzner P, Muller A, Deschner F, Huller M, Abendroth K, Hein G, Stein G (1998) Relationship between disease activity and serum levels of vitamin D metabolites and PTH in rheumatoid arthritis. Calcif Tissue Int 62(3):193–198PubMedCrossRef
24.
Zurück zum Zitat Lange U, Teichmann J, Strunk J, Muller-Ladner U, Schmidt KL (2005) Association of 1.25 vitamin D3 deficiency, disease activity and low bone mass in ankylosing spondylitis. Osteoporos Int 16(12):1999–2004. doi:10.1007/s00198-005-1990-5 PubMedCrossRef Lange U, Teichmann J, Strunk J, Muller-Ladner U, Schmidt KL (2005) Association of 1.25 vitamin D3 deficiency, disease activity and low bone mass in ankylosing spondylitis. Osteoporos Int 16(12):1999–2004. doi:10.​1007/​s00198-005-1990-5 PubMedCrossRef
26.
27.
Zurück zum Zitat Bianchi ML, Bardare M, Caraceni MP, Cohen E, Falvella S, Borzani M, DeGaspari MG (1990) Bone metabolism in juvenile rheumatoid arthritis. Bone Miner 9(2):153–162PubMedCrossRef Bianchi ML, Bardare M, Caraceni MP, Cohen E, Falvella S, Borzani M, DeGaspari MG (1990) Bone metabolism in juvenile rheumatoid arthritis. Bone Miner 9(2):153–162PubMedCrossRef
28.
Zurück zum Zitat Consolaro A, Ruperto N, Bazso A, Pistorio A, Magni-Manzoni S, Filocamo G, Malattia C, Viola S, Martini A, Ravelli A (2009) Development and validation of a composite disease activity score for juvenile idiopathic arthritis. Arthritis Rheum 61(5):658–666. doi:10.1002/art.24516 PubMedCrossRef Consolaro A, Ruperto N, Bazso A, Pistorio A, Magni-Manzoni S, Filocamo G, Malattia C, Viola S, Martini A, Ravelli A (2009) Development and validation of a composite disease activity score for juvenile idiopathic arthritis. Arthritis Rheum 61(5):658–666. doi:10.​1002/​art.​24516 PubMedCrossRef
32.
Zurück zum Zitat Update (1997) Prevalence of overweight among children, adolescents, and adults–United States, 1988–1994. MMWR Morb Mortal Wkly Rep 46(9):198–202 Update (1997) Prevalence of overweight among children, adolescents, and adults–United States, 1988–1994. MMWR Morb Mortal Wkly Rep 46(9):198–202
33.
Zurück zum Zitat Harris SS, Dawson-Hughes B (1998) The association of oral contraceptive use with plasma 25-hydroxyvitamin D levels. J Am Coll Nutr 17(3):282–284PubMed Harris SS, Dawson-Hughes B (1998) The association of oral contraceptive use with plasma 25-hydroxyvitamin D levels. J Am Coll Nutr 17(3):282–284PubMed
35.
Zurück zum Zitat Holick MF (2004) Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 80(6 Suppl):1678S–1688S. doi:80/6/1678S PubMed Holick MF (2004) Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 80(6 Suppl):1678S–1688S. doi:80/​6/​1678S PubMed
37.
39.
40.
Zurück zum Zitat Ish-Shalom S, Segal E, Salganik T, Raz B, Bromberg IL, Vieth R (2008) Comparison of daily, weekly, and monthly vitamin D3 in ethanol dosing protocols for two months in elderly hip fracture patients. J Clin Endocrinol Metab 93(9):3430–3435. doi:10.1210/jc.2008-0241 PubMedCrossRef Ish-Shalom S, Segal E, Salganik T, Raz B, Bromberg IL, Vieth R (2008) Comparison of daily, weekly, and monthly vitamin D3 in ethanol dosing protocols for two months in elderly hip fracture patients. J Clin Endocrinol Metab 93(9):3430–3435. doi:10.​1210/​jc.​2008-0241 PubMedCrossRef
41.
Zurück zum Zitat Saurenmann RK, Rose JB, Tyrrell P, Feldman BM, Laxer RM, Schneider R, Silverman ED (2007) Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort: ethnicity as a risk factor. Arthritis Rheum 56(6):1974–1984. doi:10.1002/art.22709 PubMedCrossRef Saurenmann RK, Rose JB, Tyrrell P, Feldman BM, Laxer RM, Schneider R, Silverman ED (2007) Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort: ethnicity as a risk factor. Arthritis Rheum 56(6):1974–1984. doi:10.​1002/​art.​22709 PubMedCrossRef
42.
Zurück zum Zitat Schwartz MM, Simpson P, Kerr KL, Jarvis JN (1997) Juvenile rheumatoid arthritis in African Americans. J Rheumatol 24(9):1826–1829PubMed Schwartz MM, Simpson P, Kerr KL, Jarvis JN (1997) Juvenile rheumatoid arthritis in African Americans. J Rheumatol 24(9):1826–1829PubMed
44.
Zurück zum Zitat Dong Y, Pollock N, Stallmann-Jorgensen IS, Gutin B, Lan L, Chen TC, Keeton D, Petty K, Holick MF, Zhu H (2010) Low 25-hydroxyvitamin D levels in adolescents: race, season, adiposity, physical activity, and fitness. Pediatrics 125(6):1104–1111. doi:10.1542/peds.2009-2055 PubMedCrossRef Dong Y, Pollock N, Stallmann-Jorgensen IS, Gutin B, Lan L, Chen TC, Keeton D, Petty K, Holick MF, Zhu H (2010) Low 25-hydroxyvitamin D levels in adolescents: race, season, adiposity, physical activity, and fitness. Pediatrics 125(6):1104–1111. doi:10.​1542/​peds.​2009-2055 PubMedCrossRef
Metadaten
Titel
25-Hydroxyvitamin D levels and juvenile idiopathic arthritis: Is there an association with disease activity?
verfasst von
Christina F. Pelajo
Jorge M. Lopez-Benitez
David M. Kent
Lori Lyn Price
Laurie C. Miller
Bess Dawson-Hughes
Publikationsdatum
01.12.2012
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 12/2012
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-011-2287-y

Weitere Artikel der Ausgabe 12/2012

Rheumatology International 12/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Aquatherapie bei Fibromyalgie wirksamer als Trockenübungen

03.05.2024 Fibromyalgiesyndrom Nachrichten

Bewegungs-, Dehnungs- und Entspannungsübungen im Wasser lindern die Beschwerden von Patientinnen mit Fibromyalgie besser als das Üben auf trockenem Land. Das geht aus einer spanisch-brasilianischen Vergleichsstudie hervor.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

VHF-Ablation nützt wohl nur bei reduzierter Auswurfleistung

02.05.2024 Ablationstherapie Nachrichten

Ob die Katheterablation von Vorhofflimmern bei Patienten mit Herzinsuffizienz die Komplikationsraten senkt, scheint davon abzuhängen, ob die Auswurfleistung erhalten ist oder nicht. Das legen die Ergebnisse einer Metaanalyse nahe.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.